ArticleJournal of translational medicine2025

Engineered macrophage membrane-coated dihydroartemisinin nanoparticles with enhanced CCR2 expression improved symptoms in MRL/LPR mice by metabolic reprogramming of proinflammatory macrophages.

Li Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.